相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Changing Patterns of Tumor Necrosis Factor Inhibitor Use in 9074 Patients with Rheumatoid Arthritis
Yusuf Yazici et al.
JOURNAL OF RHEUMATOLOGY (2009)
Utilization Trends of Tumor Necrosis Factor Inhibitors Among Patients with Rheumatoid Arthritis in a United States Observational Cohort Study
Susan J. Lee et al.
JOURNAL OF RHEUMATOLOGY (2009)
Do changes in prescription practice in patients with rheumatoid arthritis treated with biological agents affect treatment response and adherence to therapy? Results from the nationwide Danish DANBIO Registry
M. L. Hetland et al.
ANNALS OF THE RHEUMATIC DISEASES (2008)
Changing patterns of medication use in patients with rheumatoid arthritis in a Medicaid population
C. G. Grijalva et al.
RHEUMATOLOGY (2008)
The British Society for Rheumatology biologics register: 6 years on
K. L. Hyrich et al.
RHEUMATOLOGY (2008)
The burden of rheumatoid arthritis and access to treatment: uptake of new therapies
B. Joensson et al.
EUROPEAN JOURNAL OF HEALTH ECONOMICS (2008)
Trends in medication and health-related quality of life in a population-based rheumatoid arthritis register in Malmo, Sweden
M. K. Soderlin et al.
RHEUMATOLOGY (2007)
Tolerance and effectiveness of anti-tumor necrosis factor α therapies in elderly patients with rheumatoid arthritis:: A population-based cohort study
Stephane Genevay et al.
ARTHRITIS & RHEUMATISM-ARTHRITIS CARE & RESEARCH (2007)
Comparison of the response to infliximab or etanercept monotherapy with the response to cotherapy with methotrexate or another disease-modifying antirheumatic drug in patients with rheumatoid arthritis - Results from the British Society for Rheumatology Biologics Register
Kimme L. Hyrich et al.
ARTHRITIS AND RHEUMATISM (2006)
Long term safety of etanercept in elderly subjects with rheumatic diseases
R Fleischmann et al.
ANNALS OF THE RHEUMATIC DISEASES (2006)
The PREMIER study - A multicenter, randomized, double-blind clinical trial of combination therapy with adalimumab plus methotrexate versus methotrexate alone or adalimumab alone in patients with early, aggressive rheumatoid arthritis who had not had previous methotrexate treatment
FC Breedveld et al.
ARTHRITIS AND RHEUMATISM (2006)
Clinical and radiographic outcomes of four different treatment strategies in patients with early rheumatoid arthritis (the BeSt study) - A randomized, controlled trial
YPM Goekoop-Ruiterman et al.
ARTHRITIS AND RHEUMATISM (2005)
Update on the British Society for Rheumatology guidelines for prescribing TNFα blockers in adults with rheumatoid arthritis (update of previous guidelines of April 2001)
J Ledingham et al.
RHEUMATOLOGY (2005)
Therapeutic effect of the combination of etanercept and methotrexate compared with each treatment alone in patients with rheumatoid arthritis: double-blind randomised controlled trial
L Klareskog et al.
LANCET (2004)
Remission in rheumatoid arthritis: agreement of the disease activity score (DAS28) with the ARA preliminary remission criteria
J Fransen et al.
RHEUMATOLOGY (2004)
Combination of infliximab and methotrexate therapy for early rheumatoid arthritis - A randomized, controlled trial
EWS Clair et al.
ARTHRITIS AND RHEUMATISM (2004)
A comparison of etanercept and methotrexate in patients with early rheumatoid arthritis
JM Bathon et al.
NEW ENGLAND JOURNAL OF MEDICINE (2000)